+ All Categories
Home > Documents > 16 Pathology of Lipid Met

16 Pathology of Lipid Met

Date post: 07-Apr-2018
Category:
Upload: yasingada
View: 218 times
Download: 0 times
Share this document with a friend
52
 Pathology of lipid metabolism 
Transcript
Page 1: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 1/52

Pathology of lipidmetabolism

Page 2: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 2/52

LIPOPROTEIN METABOLISM

Page 3: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 3/52

• Fredrickson (WHO)classification is based on theappearance of a fastingplasma sample after standing for 12 hours at 4’C

and analysis of it’scholesterol and triglyceride

content.

Page 4: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 4/52

FREDRICKSON (WHO) CLASSIFICATION OF DYSLIPIDAEMIA

Page 5: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 5/52

GENETIC REASONS OF DYSLIPIDAEMIA

IIa IIb

IIa IIb

I

I

Page 6: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 6/52

XANTHELASMAS in younger individuals (age <40

years) usually indicate hypercholesterolaemia

Page 7: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 7/52

TENDON XANTHOMAS are associated withfamilial hypercholesterolaemia

Page 8: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 8/52

ARCUS SENILIS

Page 9: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 9/52

ERUPTIVE XANTHOMAS (hypertriglyceridaemia)

Page 10: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 10/52

COMMON REASONS OF SECONDARY HYPERLIPIDAEMIA

Page 11: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 11/52

LIPID- LOWERING DIETARY GUIDELINES

Page 12: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 12/52

LIPID-LOWERING DRUGS

Page 13: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 13/52

PALMAR XANTHOMAS BEFORE TREATMENT

Page 14: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 14/52

AFTER TREATMENT

Page 15: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 15/52

• Atherosclerosis is a wide-spread pathology, manifestedchiefly by the deposition of cholesterol in arterial walls,which results in the formation of

lipid plaques (atheromas).

Page 16: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 16/52

ATHEROMA IN CORONARY ARTERIES

Page 17: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 17/52

• Lipid plaques are specificforeign bodies around whichthe connective tissue develops

abnormally (this process iscalled sclerosis). This leads to

the calcification of the impairedsite of a blood vessel .

Page 18: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 18/52

• The blood vessels becomeinelastic and compact, theblood supply through thevessels is impeded, and theplaques may develop intothrombi.

Th i f h l i i

Page 19: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 19/52

• The main reason of atherosclerosis ishyperlipoproteinemia.

• All of the lipoproteins, exceptingchylomicrons (large size), are capableof penetrating the vessel wall.

• However, α -lipoproteins (HDL) which

are rich in proteins and phospholipids,are liable to an easy breakdown withinthe vessel wall or can be easy removedbecause of their small size.∀β -lipoproteins (LDL) and, partly, pre- β -

lipoproteins (VLDL) containing muchcholesterol exhibit atherogenic

properties.

Page 20: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 20/52

Page 21: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 21/52

Composition

of theplasmalipoproteins.

Page 22: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 22/52

• It is considered to be that modified(oxidized) LDL are very dangerous.Because they are captured by the cells(macrophages with non-specific receptors innon-regulating process). That’s whyantioxidants as V. E., β -carotene andascorbic acid can decrease development of

atherosclerosis.

Page 23: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 23/52

Role of oxidazed lipoproteins in plaqueformation in arterial wall.

Page 24: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 24/52

Page 25: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 25/52

Page 26: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 26/52

Page 27: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 27/52

Page 28: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 28/52

The vascular wall can exert asubstantial effect on both:

• 1) the rate of penetration of

lipoproteins inside the vessel and

• 2) their subsequent history (for example, hypertension)

Page 29: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 29/52

The main internal factors of atherosclerosis development are:

• 1) hypercholesterolemia;

•2) hypertension.

Page 30: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 30/52

3 groups of patients1) Concentration of cholesterol in the blood is

less than 2 g/L2) Concentration of cholesterol in the bloodis within 2-3,5 g/L ( carry out prophylaxis,dietetics )

3) Concentration of cholesterol in the blood ismore than 3,5 g/L ( drug therapy and radicalmethods (plasmophoresis, hemosorbtion )

Page 31: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 31/52

Risk factors of atherosclerosis development • Genetic predisposition (high

concentration of LDL)• Action of stress (increase in FFA

and Acetyl-CoA ⇒ more substrate for cholesterol synthesis). Epinephrine cause

hypertension, which helps deposition of cholesterol.• Overeating of food especially reach in

cholesterol, fats and carbohydrates

(Acetyl-CoA and NADPH 2 are necessaryfor cholesterol synthesis). Usually inhumans with obesity.

Page 32: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 32/52

• Smoking.It has been observed that ischemia of

heart occurs by 2-2,5 times morefrequent , if the patient is smoking(smoking decreases HDL concentrationin the blood).

• Hypodynamia.Physical exercises promote to theincrease of HDL concentration (that iswhy hypodynamia is risk factor of atherosclerosis development).

Page 33: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 33/52

Dietetics.• We should limitconcentration of cholesterol

and saturated fatty acids.

• Fats of animal origin wemust try to exchange onvegetable fats , because theycontain unsaturated fatty acids mainlywhich are necessary for the synthesis of phospholipids.

Page 34: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 34/52

Dietetics.• We should include in the diet the

products of vegetable origin,because heteropolysaccharidesabsorb cholesterol and remove itout of the intestine.

• We must increase the concentration of vitamins (especially E, C and A ) in the

diet.

Page 35: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 35/52

Treatment• Drug therapy:

• Cholesteramine,• Cholestipole,• Clofibrate (activate lipoproteinlipase),

• Nicotinic acid (decrease the secretion of VLDL)• Radical methods : plasmopheresis,

hemosorbtion.We decrese concentration of cholesterol inplasma. That is why it’s concentration in thecells also decreases.

Page 36: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 36/52

Fatty liver (FL) Normal liver contains about 4% as total lipids

(three-fourths of which is phospholipids (PL)and one-fourth as neutral fats (TG).For a variety of reasons, lipid – mainly astriacylglycerol – can accumulate in the liver.When accumulation of lipid in liver becomeschronic, fibroid changes occur in the cells thatprogress to cirrhosis and impaired liver

function.

Page 37: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 37/52

NORMAL LIVER HISTOLOGY

Page 38: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 38/52

NORMAL LIVER HISTOLOGY

Page 39: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 39/52

FATTY LIVER

Page 40: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 40/52

ACUTE FATTY LIVER

Page 41: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 41/52

ACUTE FATTY LIVER

Page 42: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 42/52

CHRONIC FATTY LIVER

Page 43: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 43/52

CIRRHOTIC LIVER

Page 44: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 44/52

Accumulation of lipids depends upon activationfactors that lead to increase of liver fat and inhibition

of factors that lead to decrease of liver fat. Whenthere is an imbalance between 4) Mobilization

of fats intoblood to depots

from liver (hepatotoxicsubstances,

DH, starvation)

1) Influx of DietaryLipids (fat fuding)

2) Synthesis of FA(fat fuding)

3) Mobilization of FAfrom Depots to liver (DM, starvation)

5) Degradation of FA inthe liver (PM, starvation)

Factors that lead to

decrease liver fat

Factors that lead to

increase liver fat

Total lipids in normalliver = 4%

¾ as PL and ¼ as TG

Page 45: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 45/52

2 main categories of Fatty liver

– FL which is associated with raisedlevels of plasma free fatty acids.

– The second type of FL is usually due

to a metabolic block in the productionof plasma lipoproteins (VLDL).

Page 46: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 46/52

– FL which is associated with raised levels of plasma free fatty acids.

– Increasing amounts of FA are taken up by theliver and esterified. The production of VLDLdoesn’t keep pace with the influx of FFA. TGs areaccumulated, causing FL.

Increased influx of FFA and development of FLcan be in cases of

1) feeding of high fat diets,2) starvation,3) uncontrolled diabetes mellitus .In starvation and DM it can be also due to decreased

ability to secrete VLDL, because of low levels of insulin and impaired protein synthesis.

Page 47: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 47/52

– The second type of FL is usually due to a

metabolic block in the production of plasmalipoproteins (VLDL).

– The lesion may be due to

a)a block in apolipoprotein synthesis,b)a block in the synthesis of the lipoprotein

from lipid and apoliprotein combination,c)a failure in the secretory mechanism itself.

Page 48: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 48/52

• Several antibiotics (puromycin)inhibit protein synthesis and cancause FL.

• Other hepatotoxic substances actsimilarly. They include, for example,carbon tetrachloride(CCL4),chloroform, phosphorus, lead andarsenic.

• Chronic consumption of alcohol caninduce FL.

Li i f

Page 49: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 49/52

Lipotropic factorsAll substances that increase the synthesis of PLs decrease the tissue

deposition of TGs. Such substances are called lipotropic factors.

They includecholine,serine,structural components of phospholipids ,

pyridoxal phosphate (as an agent facilitating thedecarboxylation of serine phosphatides,

methionine (as a donor of methyl group)

folic acid (B9) cobalamin (B12).

They may be used as drugs preventing excessive deposition of triglycerides in the liver.

Page 50: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 50/52

Page 51: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 51/52

• 1 gr. : There is no need to carry out prophylaxisof atherosclerosis in the first group.

• 2 gr. : In group number 2, it is necessary to(carry out prophylaxis ) of atherosclerosis bymeans of diet and optimal physical exertion,refusal from smoking, limitation of stress.

• 3 gr. : >3,5 g/L. It is necessary the measures of drug therapy and radical methods of treatment(plasmophoresis, hemosorbtion)

Page 52: 16 Pathology of Lipid Met

8/6/2019 16 Pathology of Lipid Met

http://slidepdf.com/reader/full/16-pathology-of-lipid-met 52/52

• Carbon tetrachloride induces the formation of

free radicals (CCL3) that disrupt lipidmembranes in the endoplasmic reticulum bythe formation of lipid peroxides.

• As the result, this affects the secretorymechanism itself or the conjugation of the lipidwith apolipoprotein.

• That’s why some protection against carbon

tetrachloride can be provided by theantioxidant action of vitamin E – supplementeddiets.


Recommended